Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Damiano Baroncini, Angelo Ghezzi, Clara Guaschino, Lucia Moiola, Massimo Filippi, Antonio Ianniello, Carlo Pozzilli, Roberta Lanzillo, Vincenzo Brescia Morra, Monica Margoni, Paolo Gallo, Graziella Callari, Luigi Maria Edoardo Grimaldi, Giacomo Lus, Massimiliano Calabrese, Marta Simone, Girolama Alessandra Marfia, Sarah Rasia, Daniela Cargnelutti, Giancarlo Comi, Mauro Zaffaroni, María Trojano, Diego Centonze, Ruggero Capra, Marco Capobianco, Alice Laroni, Antonio Uccelli, Antonio Gallo, Francesco Patti, Maura Danni, Claudio Gasperini, G. Coniglio (2022). Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study. , 43(11), DOI: https://doi.org/10.1007/s10072-022-06211-8.
